An innovative study, dubbed “the last roll of the dice” for a new generation of HIV vaccinations, is nearing completion. The PrEPVacc trial is investigating two vaccinations alongside two kinds of pre-exposure prophylaxis (PrEP) to assess vaccine efficacy while providing protection against HIV transmission. Its triumph, spearheaded by Africans and …
Read More »